SGLT-2 inhibitors for inhibiting the Progression of chronic Kidney Disease

被引：1
|
作者：
Heine, Gunnar Henrik [1 ]
机构：
[1] AGAPLESION MARKUS KRANKENHAUS, Med Klin 2, Wilhelm Epstein Str 4, D-60431 Frankfurt, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2020年 / 145卷 / 11期
关键词：
NEPHROPATHY; IRBESARTAN;
D O I：
10.1055/a-1163-7590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：762 / 766
页数：5
相关论文
共 50 条
  • [1] SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
    Jaswaney, Rahul
    Sokoloff, Samantha
    Rakita, Val
    Rubin, Daniel J.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (07) : 415 - 423
  • [2] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Claire C. J. Dekkers
    Ron T. Gansevoort
    Hiddo J. L. Heerspink
    Current Diabetes Reports, 2018, 18
  • [3] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Dekkers, Claire C. J.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    CURRENT DIABETES REPORTS, 2018, 18 (05)
  • [4] SGLT2 Inhibitors slow the Progression of chronic Kidney Disease
    不详
    DIABETOLOGE, 2019, 15 (06): : 567 - 567
  • [5] Value of SGLT-2 inhibitors in the treatment of chronic kidney disease Clinical and practical implications
    Saemann, Marcus
    Cejka, Daniel
    Schmaldienst, Sabine
    Rosenkranz, Alexander R.
    Mayer, Gert
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (3-4) : 97 - 109
  • [6] A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
    Lucia Del Vecchio
    Angelo Beretta
    Carlo Jovane
    Silvia Peiti
    Simonetta Genovesi
    Drugs, 2021, 81 : 1491 - 1511
  • [7] A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
    Del Vecchio, Lucia
    Beretta, Angelo
    Jovane, Carlo
    Peiti, Silvia
    Genovesi, Simonetta
    DRUGS, 2021, 81 (13) : 1491 - 1511
  • [8] Halting the progression of chronic kidney disease; an audit of the use of renin-angiotensin-aldosterone blockers and SGLT-2 inhibitors
    Teh, Jia Wei
    Harris, Luke
    Corcoran, Niamh
    Lappin, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2399 - I2399
  • [9] Halting the progression of chronic kidney disease; an audit of the use of renin-angiotensin-aldosterone blockers and SGLT-2 inhibitors
    Teh, Jia Wei
    Harris, Luke
    Corcoran, Niamh
    Lappin, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [10] SGLT-2 INHIBITORS DELAY KIDNEY FAILURE PROGRESSION AND REDUCE NEED OF DIALYSIS IN CHRONIC KIDNEY DISEASE PATIENTS: A META-ANALYSIS
    Mahendra, Aditya Indra
    Samsu, Nur
    Gunawan, Atma
    Rifai, Achmad
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I682 - I682
12345